12hon MSNOpinion
Misapplied pharmaceutical model prevents scaling of effective interventions, researcher argues
A new article published in the Journal of Medical Internet Research challenges the foundational research model that has ...
LCGC International Column Editor Michael Dong concludes his three-part series on HPLC fundamentals for practicing scientists ...
Learn how FTIR spectroscopy simplifies pharmaceutical formulation by providing rapid, accurate molecular analysis.
In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to ...
StockStory.org on MSN
West Pharmaceutical Services (WST) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday morning. Here’s ...
The upheaval at the FDA appears to be taking a toll on the pharmaceutical industry, according to a new analysis of key agency ...
Review Michael’s “Perspectives in HPLC” columns in 2024-2025: The Good, the Bad, and the Ugly of HPLC in Pharmaceutical ...
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug ...
The latest recall affects a generic versions of the statin medication Atorvastatin Calcium, a medication taken by around 47 ...
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...
Analysts expect Kiniksa Pharmaceuticals to report an earnings per share (EPS) of $0.35. Kiniksa Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback